The benefits of NT3 were reported in treating memory deficits, indicating its potential in inherited and acquired forms of dementias [65], which revealed that the pharmacological inhibition of HDAC3 increased BDNF expression [66] and the potential role of NT3 in AD treatment using an NT3-transduced graft [67]. The gene discussed is HDAC3; the disease is Alzheimer disease.